Risk of malignancy associated with cyclosporin use in psoriasis [1]

Dermatology

Volumn 198, Issue 3, 1999, Pages 320-

  Paul, C ^a   Hornig, F ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

BREAST CANCER; CANCER RISK; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUNG CANCER; PRIORITY JOURNAL; PSORIASIS;

CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; NEOPLASMS; PSORIASIS; RISK FACTORS;

EID: 0033048569     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018142     Document Type: Letter

References (10)